Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-18-012524)

Filing Details

Accession Number:: 0001144204-18-012524
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-02 16:01:53
Reporting Period:: 2018-03-01

Accepted Time:: 2018-03-02 16:01:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1426800	Assembly Biosciences Inc.	ASMB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238325	R William Ringo	C/O Assembly Biosciences, Inc. 11711 N. Meridian Street, Suite 310 Carmel IN 46032		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-01	1,000	$7.20	20,465	No	4	M	Direct
Common Stock	Disposition	2018-03-01	1,000	$56.37	19,465	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-03-01	1,000	$0.00	1,000	$7.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
53,000		2024-07-10	No	4	M	Direct

Footnotes

The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This option, initially representing a right to purchase 64,000 shares, became exercisable in three equal installments on July 11, 2014; July 11, 2015; and July 11, 2016.